Steigerová Jana Ph.D.
Journals
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.
The Prostate.
2018,
79(4),
352-362,
ISSN: 0270-4137,
PMID: 30499118,
The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro.
The Journal of Steroid Biochemistry and Molecular Biology.
2018,
178,
263-271,
ISSN: 0960-0760,
PMID: 29307714,